Association of MDR1 (C3435T) Polymorphism and Resistance to Carbamazepine in Epileptic Patients from Turkey
Authors:
- Nerses BebekNBNerses Bebek
- Gunay GulGGGunay Gul
- Naci CineNCNaci Cine
- 4 October 2007
- journal article
- clinical trial
- Published by S. Karger AG in European Neurology
- Vol. 59 (1-2) , 67-70
Abstract
Background and Aims: We investigated the prevalence of this multidrug resistance 1 gene (MDR1) polymorphism in drug-responsive versus drug-resistant epilepsy patients treated with carbamazepine (CBZ), which is a substrate of this protein. Methods: We genotyped the C3435T variant of MDR1 in 97 patients treated with CBZ monotherapy who had been on stable doses for more than 1 month. Our control group included 174 healthy individuals. Plasma CBZ concentrations were also measured using fluorescence polarization immunoassay. Results: We could not demonstrate any statistically significant relationship with the genotypes among drug-resistant patients (n = 44). The frequency of the homozygous mutant (TT) genotype was 15% in drug-responsive patients, 11.3% in drug-resistant patients and 25.8% in the control group. We also did not observe any significant correlation between the presence of a specific allele and CBZ plasma level/dose index. Conclusion: Our study did not support any significant association between the MDR1 (C3435T) polymorphism and resistance to CBZ in epilepsy patients from Turkey.Keywords
This publication has 14 references indexed in Scilit:
- Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsySeizure: European Journal of Epilepsy, 2006
- ABCB1 Polymorphisms Influence the Response to Antiepileptic Drugs in Japanese Epilepsy PatientsPharmacogenomics, 2006
- Refractory epilepsy: mechanisms and solutionsExpert Review of Neurotherapeutics, 2006
- Lack of Association between the C3435T Polymorphism in the Human Multidrug Resistance (MDR1) Gene and Response to Antiepileptic Drug TreatmentEpilepsia, 2005
- Définition de la pharmaco-résistance : le point de vue de l’épileptologueRevue Neurologique, 2004
- Association of Multidrug Resistance in Epilepsy with a Polymorphism in the Drug-Transporter GeneABCB1New England Journal of Medicine, 2003
- The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levelsThe Pharmacogenomics Journal, 2001
- Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProceedings of the National Academy of Sciences, 2000
- What have we learnt thus far from mice with disrupted P-glycoprotein genes?European Journal of Cancer, 1996
- Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell linesNature, 1985